1-4 of 4
Karl J. Lackner
Close
Sort by
Journal Articles

Cardiovascular and genetic determinants of platelet high responsiveness - Results from the Gutenberg Health Study

Gaukhar Baidildinova, Vincent ten Cate, Marina Panova-Noeva, Bianca Dahlen, Alexander Gieswinkel, Saskia von Ungern-Sternberg, Steffen Rapp, Konstantin Strauch, Manfred E Beutel, Norbert Pfeiffer, Karl J. Lackner, Thomas Munzel, Hugo ten Cate, Philipp S. Wild, Kerstin Jurk
Journal: Blood Advances
Blood Adv bloodadvances.2023012538.
https://doi.org/10.1182/bloodadvances.2023012538
Published: 2024
Includes: Supplemental data
Journal Articles

A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Tanja Falter, Heidi Rossmann, Laure de Waele, Charlotte Dekimpe, Charis von Auer, Nadine Müller-Calleja, Friederike Häuser, Adriana Degreif, Dana Marandiuc, Xavier Messmer, Martin Sprinzl, Karl J. Lackner, Kerstin Jurk, Karen Vanhoorelbeke, Bernhard Lämmle
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5091–5102.
https://doi.org/10.1182/bloodadvances.2023010028
Published: 2023
Includes: Supplemental data
Journal Articles

A targeted proteomics investigation of the obesity paradox in venous thromboembolism

Clinical Trials & Observations
Vincent Ten Cate, Thomas Koeck, Jürgen Prochaska, Andreas Schulz, Marina Panova-Noeva, Steffen Rapp, Lisa Eggebrecht, Michael Lenz, Julia Glunz, Madeleine Sauer, Raff Ewert, Michael Halank, Thomas Münzel, Stefan Heitmeier, Miguel A. Andrade-Navarro, Karl J. Lackner, Stavros V. Konstantinides, Kirsten Leineweber, Philipp S. Wild
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2909–2918.
https://doi.org/10.1182/bloodadvances.2020003800
Published: 2021
Includes: Supplemental data
Journal Articles

Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies

Nadine Müller-Calleja, Svenja Ritter, Anne Hollerbach, Tanja Falter, Karl J. Lackner, Wolfram Ruf
Journal: Blood Advances
Blood Adv (2018) 2 (9): 979–986.
https://doi.org/10.1182/bloodadvances.2018017095
Published: 2018